The DOI matches its Crossref record; 73 of the 74 references it cites were found in a registry or an index.
Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature
Open accessAbstract
Introduction On February 11, 2020 WHO designated the name "COVID-19" for the disease caused by "severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2), a novel virus that quickly turned into a global pandemic. Risks associated with acquiring the virus have been found to most significantly vary by age and presence of underlying comorbidity. In this rapid literature review we explore the prevalence of comorbidities and associated adverse outcomes among individuals with COVID-19 and summarize our findings based on information available as of May 15, 2020.Methods A comprehensive systematic search was performed on PubMed, Medline, Scopus, Embase, and Google Scholar to find articles published until May 15, 2020. All relevant articles providing information on PCR tested COVID-19 positive patient population with clinical characteristics and epidemiological information were selected for review and analysis.Results A total of 27 articles consisting of 22,753 patient cases from major epicenters worldwide were included in the study. Major comorbidities seen in overall population were CVD (8.9%), HTN (27.4%), Diabetes (17.4%), COPD (7.5%), Cancer (3.5%), CKD (2.6%), and other (15.5%). Major comorbidity specific to countries included in the study were China (HTN 39.5%), South Korea (CVD 25.6%), Italy (HTN 35.9%), USA (HTN 38.9%), Mexico, (Other 42.3%), UK (HTN 27.8%), Iran (Diabetes 35.0%). Within fatal cases, an estimated 84.1% had presence of one or more comorbidity. Subgroup analysis of fatality association with having comorbidity had an estimated OR 0.83, CI [0.60-0.99], p<0.05.Conclusions Based on our findings, hypertension followed by diabetes and cardiovascular diseases were the most common comorbidity seen in COVID-19 positive patients across major epicenters world-wide. Although having one or more comorbidity is linked to increased disease severity, no clear association was found between having these risk factors and increased risk of fatality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“data from Wuhan, China showed that age was the primary risk factor associated with COVID-19 progression to acute respiratory distress syndrome (ARDS) and end-organ failure7”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Research works printed but not linked: 9
- Age, 2020, Existing Conditions of COVID-19 Cases and deaths, WorldoMeter
- 2020, COVID-19 world map and mortality analysis, John Hopkins University
- 2020, Predicting the next phase of the covid-19 epidemic: changes in human behavior, Institute for Health Metrics and Evaluation
- McIntosh, 2020, Coronavirus disease 2019 (COVID-19): Epidemiology, virology, clinical features, diagnosis, and prevention, In:UpToDate
- 2020, Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019, MMWR Morb Mortal Wkly Rep
- 2020, Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eighth update, European Center for Disease Prevention and Control
- Bommer, 2020, CDC offers guidance to patients with chronic disease 'living with uncertainty' during COVID-19, Healio Rheumatology
- Mandal, 2020, What happens when COVID-19 and cardiovascular diseases mix, Lifesciences
- Yang, 2020, Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis, Int J Infect Dis, 94, 91, 10.1016/j.ijid.2020.03.017 · DOI · Paper page
Cited by
Sorted by citations
Items 301–325 of 325
Martins‐Filho, P. R., Santana, L. A. D. M., & Costa, F. W. G. (2024) · Oral Diseases · doi:10.1111/odi.14924
Jasim, M. T., Noraldeen, M. Y., & Al-kadhi, N. A. (2023) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_358_22
COVID-19 Outbreaks in Co-Morbid Patients: A Pursuit for Biomarkers
Jamil, K., Chaitanya, N., Gade, S., & Asimuddin, M. (2023) · Asian Journal of Emerging Research · doi:10.3923/ajerpk.2023.01.08
Muntaha, S. T., Ayaz, H., Mahmood, H., Kulsoom, A., Tayyab, M., & Farooq, A. (2024) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v28i1.2424
Inayah, A. F., Putri, G. S., & Anggraeni, A. D. (2024) · Eduvest - Journal Of Universal Studies · doi:10.59188/eduvest.v4i5.1277
Farabi, M. J. A., Saputra, P. B. T., Marantika, A., Pasahan, D., Rami, R., & Oktaviono, Y. H. (2024) · Journal of the Pakistan Medical Association · doi:10.47391/jpma.s6-acsa-03
Incidence and severity of COVID-19 among HIV positive patients with existing co-morbidities
Lwembe, R., Guni, J. N., Muyeku, M. I., Wekesa, L., Muriuki, J. K., Mwangi, J., Maiyo, A. K., Chege, J., Kinyua, J., Olungae, D., et al. (2024) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2024.11.00277
Somatic and neurological comorbidities in COVID-19 with fatal outcome
Ignatieva, O. I., Валерьевич, С. А., Павелкина, В. Ф., Николаевич, И. В., & Анатольевич, Е. А. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-502
Ahmed, M., makhlof, M. E., Kotgire, A. B., Omar, M., & Ahmed, S. I. (2024) · Cureus · doi:10.7759/cureus.73578
Akhavnnezhad, S., Talebi, S. S., Farkhani, E. M., & Rohani-Rasaf, M. (2025) · BMC Public Health · doi:10.1186/s12889-025-22523-8
Joseena, S. V. M., Balakrishnan, A., Cyril, A., Roy, A., Saji, J., Rohitha, R., Thomas, S., & Surya Mol, P. R. (2025) · International Journal of Advances in Nursing Management · doi:10.52711/2454-2652.2025.00002
The Effect of COVID-19 on Acne Exacerbation
Zaman, M. A., & AlEdani, E. M. (2025) · Updates in clinical dermatology · doi:10.1007/978-3-031-87791-9_2
Household Financial Wellbeing During the COVID ‐19 Pandemic: An Instrumental Variable Approach
Porto, N., Mottola, G. R., & Valdes, O. M. (2025) · Journal of Consumer Affairs · doi:10.1111/joca.70018
COVID-19, más allá de la enfermedad
Cuevas, Y. V. A., Álvarez-Sánchez, A. D. P., Avendano, L. A. B., & Rodríguez, I. A. M. (2024) · Revista Cuarzo · doi:10.26752/cuarzo.v30.n1.664
Jwan, M. A., Alshriaf, M. A., & Jouan, I. A. (2020) · Journal of Basic Sciences · doi:10.59743/jbs.v33i2.177
Eberle, C., & Stichling, S. (2021) · Figshare · doi:10.6084/m9.figshare.16584494
Imanieh, M., Amirzadehfard, F., Zoghi, S., Sehatpour, F., Jafari, P., Hassanipour, H., Feili, M., Mollaie, M., Bostanian, P., Mehrabi, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26558864
Abdel-Qadir, H., Austin, P. C., Sivaswamy, A., Chu, A., Wijeysundera, H. C., & Lee, D. S. (2023) · Figshare · doi:10.6084/m9.figshare.22623682
Socioeconomic status and risk of COVID-19 hospitalization in the All of Us Research Program
Choi, A., Craver, A., Luo, J., Yang, Y., & Aschebrook‐Kilfoy, B. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1690430
Moabelo, K. J., Mangena, P., Setati, M. E., & Nchabeleng, M. J. (2026) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v41i1.782
Investigating Dermatological Side Effects of COVID‐19 Vaccination Among the Bangladeshi Population
Tabassum, S., Roni, M. R. H., Rahat, M. T. I., Sumi, M. S. A., Resma, M. N. J., Bhuiyan, M. A. R., & Kibria, M. K. (2026) · Dermatologic Therapy · doi:10.1155/dth/9521685
Murgel, M. F., Quintana, M. D. S. B., Pinheiro, R. O., da Silva, V. S., Moura, C. L. D. S., Oliveira, V. D. G., Valete‐Rosalino, C. M., & da Silva, G. M. S. (2026) · Frontiers in Epidemiology · doi:10.3389/fepid.2026.1770145
Fungal Infections in Severe Cases of Patients with COVID-19
Al-Saidi, S. R. H., Abboud, Z. H., & Al-Saadi, H. A. (2026) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_397_23
Pérez-Vielma, N. M., Torres, C. M. A., Monroy, V. S., Padilla, E. A. L., Sánchez-Camacho, J. V., Díaz, C. A. G., Miliar-García, Á., Hernández, S. R., López, G. C. V., López, E. R., et al. (2026) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2026.106025
İŞLER, Y., Kaya, H., Ortabük, A. F., Yüksel, M., & Ay, M. O. (2026) · Vaccines · doi:10.3390/vaccines14100841
Metadata
- Authors
- Bajgain, K. T., Badal, S., Bajgain, B. B., & Santana, M. J.
- Affiliations
- University of Minnesota (US)
- University of Calgary (CA)
- Corresponding author
- Bajgain, Bishnu B.
- Venue
- American Journal of Infection Control
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 49
- Issue
- 2
- Pages
- 238-246
- ISSN
- 0196-6553 (ISSN-L)
- PMC
- PMC7351042
- OpenAlex
- W3042070402
- Cited by
- 328
- References
- 74
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 23 · 2023: 57 · 2022: 105 · 2021: 102
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Infection Control (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Libraries and Cultural Resources (University of Calgary) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- COVID-19 pandemic, SARS-CoV-2, comorbidities, hypertension, diabetes mellitus, cardiovascular disease, chronic obstructive pulmonary disease, chronic kidney disease, cancer, COVID-19 mortality, disease severity, risk factors
- MeSH terms
- COVID-19, SARS-CoV-2, Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Hypertension, Male, Middle Aged, Neoplasms, Global Health, Comorbidity, Prevalence, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
